Cancer Genetics to raise $15M in secondary offering; St. Jude critic acknowledges Durata fix;

@FierceMedDev: Don't forget to nominate! We're looking for 15 of the fiercest device and diagnostics developers. Info | Follow @FierceMedDev

@DamianFierce: Study: Medical devices spur complications for kids. More | Follow @DamianFierce

@MarkHFierce: Teleflex has long pursued M&A involving small startups with promising tech. This time, it's Israel's Eon Surgical. Article | Follow @MarkHFierce

 @MichaelGFierce: BioFire scores CE mark for sepsis blood Dx. Item | Follow @MichaelGFierce

> One of the doctors who first flagged problems with St. Jude Medical's ($STJ) Riata lead is now saying the company has righted the issue with Durata. News

> Cancer Genetics has filed to raise $15 million from a secondary offering. Story (sub. req.)

> San Antonio's med tech sector is poised for some major growth, the San Antonio Business Journal reports. Item

> University of Washington spinout Cardiac Insight won FDA clearance to start selling a tiny atrial fibrillation-monitoring device. Story

> Qiagen ($QGEN) is expanding its sequencing capabilities, planning to launch another 20 validated gene panels. More

> Switzerland's Diagnoplex has raised about $1.4 million to secure a CE mark for its Colox colon cancer diagnostic. Item

> In a blog post, the FDA uses the example of Synthes' illegal marketing of its Norian XR bone cement to illustrate the role of the agency's Office of Criminal Investigation. Article

> A University of Buffalo researcher will begin work on developing an ultrasonic intra-body communication network for bionic implants. Story

Biotech News

@FierceBiotech: From IMS Health scoops up Incential Software. Report | Follow @FierceBiotech

@RyanMFierce: Sanofi seeks compelling case for next-generation Lantus in diabetes war. Article | Follow @RyanMFierce

@EmilyMFierce: Spinal muscular atrophy patients could benefit from new drug. Story | Follow @EmilyMFierce

> Royalty Pharma drops 'game-changer' on Elan with up to $8B bid. More

> Canada's Medicago reports positive early data for H7N9 vaccine. Story

> Pharma giant AbbVie backs biotech startup working on oral bowel drug. News

Pharma News

@FiercePharma: Mini-Pfizer? Endo to cut 700 jobs, review asset sales in refocus on core pharma biz. Yesterday's story | Follow @FiercePharma

@EricPFierce: Is Teva and its generic of Avandia the big winner in today's vote? More | Follow @EricPFierce

@CarlyHFierce: The FDA advisory panel reached a verdict on Avandia yesterday. How would you have voted? Story | Follow @CarlyHFierce

> Battle of weight-loss drugs begins as Arena launches Belviq next week. Article

> Sanofi uses multi-pronged strategy to defend its place in diabetes market. Story

> Reuters: Forest, Icahn negotiate to avoid 3rd proxy battle. More

Suggested Articles

U.K.-based surgery robot developer CMR Surgical has begun rolling out its Versius platform to the NHS, completing its first procedures in Europe.

The former Fierce 15 winner’s SuperMap program was cleared to guide electrophysiologists in the treatment of stable and transient arrhythmias.

Insulet announced new agreements with Abbott and Dexcom to connect their continuous glucose monitors with its upcoming tubeless, digital insulin pump,